Log In
Print
BCIQ
Print
Print this Print this
 

AMX-808

Also known as: formerly VRS-808

  Manage Alerts
Collapse Summary General Information
Company Amunix Operating Inc.
DescriptionGlucagon attached to Amunix's recombinant XTEN technology
Molecular Target Glucagon receptor (GCGR)
Mechanism of ActionGlucagon receptor agonist
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetes
Indication DetailsTreat nocturnal hypoglycemia in diabetic patients; Treat Type II diabetes and obesity
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today